JAPONICA OWENS: Open Payments
NPI 1770823916 · GREER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,550 in 30 payments from 11 companies in 2025. Trend: 2023 $552 · 2024 $1,437 · 2025 $1,550
Food & beverage: $1,383Education: $167
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $443 |
| Amgen Inc. | 5 | $355 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $182 |
| Astellas Pharma US Inc | 2 | $167 |
| Novo Nordisk Inc | 3 | $142 |
| Dexcom, Inc. | 1 | $123 |
| PFIZER INC. | 4 | $70 |
| Eisai Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
Products named: OTEZLA, BREZTRI, CAPLYTA, Ozempic, FARXIGA, DEXCOM G7 GSS (161), EVENITY, AIRSUPRA.
Industry payments across SC — which companies pay providers there.
